Clinical trial
A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency
NCT02337569 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency
- Lead sponsor
- Nobelpharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- November 30, 2015
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
zinc deficiency